Form 13F security
NBIX · Neurocrine Biosciences, Inc.
Class COM
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| Dodge & Cox | 2026-06-30 | $941M | 0.5% | SH 5,584,707 | — |
| Bridgewater Associates, LP | 2026-06-30 | $35M | 0.1% | SH 205,677 | — |
| Fisher Asset Management, LLC — Ken Fisher | 2026-06-30 | $23M | <0.1% | SH 135,104 | — |
Total $999M across 3 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
Filed rows (3) — as filed
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| Dodge & Cox | COM | — | $941M | 0.5% | SH 5,584,707 | 0001193125-26-349535 |
| Bridgewater Associates, LP | COM | — | $35M | 0.1% | SH 205,677 | 0001350694-26-000003 |
| Fisher Asset Management, LLC | COM | — | $23M | <0.1% | SH 135,104 | 0000850529-26-000006 |